Discover All Events

GenomicsConnect 2026 is a strategic healthcare conference designed to examine the rapidly developing role of genomics within the NHS and the wider UK healthcare landscape. Taking place on 24 September 2026 at etc.venues, Prospero House in London, the event provides an opportunity for healthcare professionals, clinical specialists, NHS leaders and organisations working across diagnostics and medical sciences to explore how genomic medicine is moving from specialist research environments into routine clinical practice. The growth of genomic medicine is creating significant opportunities to improve diagnosis, treatment and long-term patient outcomes. Advances in genomic testing are helping healthcare professionals understand the biological causes of disease, identify patients who may benefit from targeted therapies and support increasingly personalised approaches to care. As genomic technologies continue to develop, the challenge for healthcare systems is no longer simply about generating genomic data. It is also about integrating that information effectively into clinical pathways, ensuring that professionals have the right skills and infrastructure, and making sure patients can benefit from innovation in a safe, equitable and sustainable way. GenomicsConnect 2026 provides a dedicated platform for examining these developments and considering the practical requirements for successful clinical integration. The conference is particularly relevant to NHS professionals involved in genomics, diagnostics, pathology, cancer care, rare disease services, laboratory medicine and personalised treatment strategies. Exploring the Changing Role of Genomics in Healthcare Genomic medicine is becoming increasingly important across multiple areas of healthcare. The NHS Genomic Medicine Service has helped create a framework for integrating genomic testing into patient pathways, while advances in sequencing technologies and data analysis are expanding the potential applications of genomic information. For healthcare providers, this transformation brings both opportunities and challenges. Genomic testing can support earlier and more accurate diagnosis, help identify inherited conditions and provide additional information that may influence treatment decisions. However, effective implementation requires collaboration between clinical teams, laboratories, scientists, technology specialists and healthcare leaders. GenomicsConnect 2026 is positioned to support this conversation by bringing together professionals who are directly involved in the development and delivery of genomic healthcare. The event offers an environment where delegates can examine emerging approaches, share experiences and consider how genomic services can be integrated into everyday clinical practice. Genomics and Personalised Medicine One of the most important themes surrounding genomic healthcare is the development of personalised medicine. Traditional healthcare approaches often rely on broadly applicable treatment strategies, whereas genomic information can provide additional insight into how an individual patient may respond to particular therapies. This is particularly significant in areas such as oncology, where genomic testing can help identify molecular characteristics of tumours and potentially guide treatment choices. Similar developments are taking place in rare disease diagnosis and pharmacogenomics, where genetic information may contribute to more informed decisions about medicines. The conference provides a valuable setting for professionals to explore how personalised medicine is developing and what is required to translate scientific advances into practical clinical benefits. Delegates can consider the role of genomic testing in supporting better decision-making while also examining the infrastructure, governance and workforce requirements associated with implementation. Supporting Cancer Care Through Genomic Innovation Cancer is one of the most prominent areas where genomic medicine is influencing healthcare delivery. Genomic analysis can provide insights into the biological characteristics of cancers and may help clinicians understand which treatment approaches are most appropriate for particular patients. The integration of genomics into cancer pathways requires close collaboration between oncologists, pathologists, genomic laboratories, molecular scientists and other healthcare professionals. It also depends on efficient testing pathways and the ability to interpret complex results in a clinically meaningful way. GenomicsConnect 2026 offers an opportunity for professionals working in cancer and diagnostics to consider the role of genomic technologies within modern oncology. Discussions around clinical integration can help delegates understand how genomic information may contribute to more targeted and individualised approaches to cancer care. Improving Rare Disease Diagnosis Rare diseases can present significant diagnostic challenges for patients and healthcare professionals. Many conditions may involve complex symptoms that are difficult to identify through conventional diagnostic approaches. Genomic testing has the potential to support the identification of underlying genetic causes and help reduce lengthy diagnostic journeys. The use of genomic technologies in rare disease pathways also highlights the importance of multidisciplinary collaboration. Clinicians, genetic counsellors, laboratory specialists and genomic scientists may all contribute to the diagnostic process. By bringing together professionals from different areas of healthcare, GenomicsConnect 2026 can support knowledge exchange around the practical challenges and opportunities associated with genomic diagnosis. The event is relevant to professionals seeking to understand how genomic services can be embedded more effectively into patient pathways. The Importance of Clinical Integration Generating genomic data is only one part of the healthcare transformation. The information must also be incorporated into clinical workflows in ways that are accessible, reliable and useful to healthcare professionals. Clinical integration involves multiple considerations, including laboratory capacity, digital infrastructure, data interpretation, workforce development and communication between specialist services and frontline teams. Healthcare organisations must also consider how genomic information is stored, accessed and incorporated into patient records. The conference focuses on the broader journey from genomic innovation to practical healthcare delivery. This makes it particularly relevant to NHS leaders and professionals who are responsible for planning, implementing or managing genomic services. Data, Technology and Healthcare Infrastructure The growth of genomic medicine is closely connected with advances in digital technology. Modern genomic testing can generate significant volumes of complex data, creating a need for robust systems that can support analysis, interpretation and secure information management. Healthcare organisations must therefore consider how genomic data interacts with existing digital infrastructure. Effective systems can help professionals access relevant information and support more coordinated decision-making across different parts of the healthcare system. Technology leaders and healthcare professionals can use events such as GenomicsConnect 2026 to explore the relationship between genomics and digital transformation. The conference provides an opportunity to consider how technology can support the practical delivery of genomic medicine while maintaining appropriate standards of security and governance. Developing the Genomics Workforce Successful genomic integration also depends on having a skilled workforce. As genomic testing becomes more common, healthcare professionals across different disciplines may need greater awareness of genomics and its relevance to clinical practice. Specialist genomic professionals also play a critical role in interpreting complex results and supporting clinical teams. Training, education and professional development are therefore important components of the wider genomic transformation. The event can provide a useful forum for healthcare professionals to learn from peers and understand how organisations are responding to changing workforce requirements. By sharing experiences, delegates can explore approaches to skills development and multidisciplinary collaboration. Knowledge Sharing and Professional Networking A key benefit of attending GenomicsConnect 2026 is the opportunity to connect with professionals working across different areas of healthcare. Genomics is inherently multidisciplinary, bringing together clinical, scientific, technological and operational expertise. Networking can help delegates exchange practical experiences, identify emerging trends and develop professional relationships. For NHS organisations, collaboration can also support the sharing of ideas about service improvement and implementation. The conference environment encourages delegates to engage with topics that extend beyond individual specialties. This wider perspective can help professionals understand how genomics fits into the broader transformation of healthcare delivery. A Strategic Forum for NHS Healthcare Professionals GenomicsConnect 2026 is particularly relevant to NHS professionals who are involved in planning and delivering modern diagnostic and clinical services. The event can help delegates consider the strategic implications of genomic medicine and how organisations can prepare for continued technological development. For senior leaders, the conference provides an opportunity to examine the operational and strategic considerations associated with genomic integration. For clinical and scientific professionals, it offers a platform for exploring developments in diagnostics and personalised healthcare. The event also creates opportunities for delegates to engage with peers and consider how emerging genomic approaches could contribute to better patient outcomes. Building the Future of Genomic Healthcare The future of genomic medicine will depend on successful collaboration between healthcare organisations, clinical teams, scientific communities and technology specialists. As genomic testing becomes increasingly integrated into patient pathways, healthcare systems will need to continue adapting their infrastructure, workforce and processes. GenomicsConnect 2026 provides a timely opportunity to examine this transformation. The conference brings together themes including genomic medicine, clinical integration, diagnostics, personalised treatment and healthcare innovation, making it relevant to professionals who want to understand the direction of genomic healthcare in the NHS. By attending, delegates can gain broader insight into the challenges associated with implementing genomic services while exploring the opportunities created by scientific and technological advances. The event also supports professional knowledge exchange and networking among individuals working in related areas. With Convenzis' focus on bringing together senior NHS and public-sector professionals, the conference is positioned as a strategic forum for discussions around healthcare transformation. Convenzis states that its conferences are designed to connect leaders and professionals to share knowledge and support improvements in public services, while the GenomicsConnect event itself highlights the increasing role of genomic medicine across cancer, rare disease diagnostics, pharmacogenomics and personalised treatment. Overall, GenomicsConnect 2026 offers an important platform for professionals seeking to understand how genomics is shaping the future of healthcare. From improving diagnostic pathways and supporting personalised medicine to strengthening clinical integration and digital infrastructure, genomic technologies have the potential to influence many aspects of patient care. For NHS leaders, clinicians, healthcare scientists, genomic specialists and diagnostics professionals, the conference provides an opportunity to explore these developments in a focused professional environment. The combination of strategic discussion, knowledge sharing and networking can help delegates gain a clearer understanding of the opportunities and practical considerations associated with the next generation of genomic healthcare. As the NHS continues to develop its genomic capabilities, events such as GenomicsConnect 2026 can play an important role in bringing together the people and expertise needed to support sustainable innovation. The conference therefore represents a valuable opportunity to engage with the evolving landscape of genomic medicine and consider how advances in science and technology can be translated into meaningful improvements for patients and healthcare services.

Connectivity is the catalyst for innovation. In an effort to strengthen the local engineering community, Hutchinson Stop-Choc is organizing the Slough Industrial Excellence Networking Night. This evening event, held at a premier venue near the Slough Trading Estate, is designed to break down the silos between different engineering disciplines. While Slough is a global hub for logistics and data centers, its manufacturing and engineering heritage remains its strongest asset. This event provides an informal yet professional platform for CEOs, engineers, and apprentices to share ideas and explore potential collaborations. The night begins with a brief "State of the Industry" address by the Managing Director of Hutchinson Stop-Choc UK, highlighting the recent growth and technological milestones achieved within the region. Following this, the floor is open for structured networking, with dedicated zones for Aerospace, Defense, and Transportation sectors. Whether you are looking for a new supplier, a technical partner, or simply want to catch up with colleagues across the estate, this evening promises valuable connections. We believe that by fostering a strong local network, we can collectively tackle the global challenges of the coming decade. Hors d'oeuvres and locally brewed beverages will be served. Space is limited to 150 attendees to ensure high-quality interactions, so early registration is highly recommended for this cornerstone event of the Slough business calendar.

The West Midlands Renewable Energy Expo is the premier regional event for the clean energy sector, hosted in the heart of Coventry. This large-scale exhibition brings together the brightest minds in wind, solar, and hydrogen technology. As the UK strives toward its 2050 targets, this expo serves as a critical junction for developers, investors, and engineers to share insights and forge new partnerships. The expo floor will feature over 50 exhibitors ranging from multinational energy providers to niche technology startups. The primary focus of this year’s event is "Energy Security through Diversification." Sessions will delve into the technicalities of grid integration for decentralized energy sources and the role of battery storage in stabilizing local power networks. Professional engineers will find the technical seminars particularly valuable, as they cover the latest British Standards for renewable installations. A highlight of the expo is the "Innovation Pitch," where regional startups present their climate solutions to a panel of venture capitalists and industry veterans. This provides a unique glimpse into the future of energy in the UK. Climate Change Solutions Ltd. will be hosting a dedicated pavilion focused on professional consultancy for large-scale solar farm developments and planning permissions. Beyond the technical exhibits, the event emphasizes the socio-economic benefits of the renewable shift. Keynote addresses will highlight job creation in the "Green Collar" sector and the potential for Coventry to become a hub for hydrogen research. This expo is essential for anyone involved in the infrastructure, planning, or financing of the UK's energy future. Whether you are looking to procure new technology or find a strategic partner, the West Midlands Renewable Energy Expo offers the ideal environment for professional growth and industry advancement.

The CS International Conference, organized by Angel Business Communications Limited, stands as the premier global gathering for the compound semiconductor industry. Held in the heart of the UK's engineering hub, Coventry, this event brings together the entire value chain—from equipment manufacturers and wafer suppliers to chip designers and systems integrators. As the industry moves toward a future defined by 5G, electric vehicles, and high-efficiency power electronics, CS International provides the essential platform for discussing the technical hurdles and commercial opportunities that lie ahead. The 2026 edition focuses heavily on the transition from silicon to wider bandgap materials such as Silicon Carbide (SiC) and Gallium Nitride (GaN). Attendees will gain deep insights into how these materials are revolutionizing the automotive sector by extending the range of EVs and reducing charging times. Furthermore, the event explores the role of Photonics and Integrated Optics in the next generation of data centers, where power density and thermal management are becoming critical bottlenecks. Experts will deliver keynote presentations on the latest breakthroughs in MOCVD growth techniques, etching, and packaging technologies that are essential for scaling production. Beyond the technical sessions, the conference is designed to foster high-level networking. The exhibition floor features leading global players showcasing live demonstrations of the latest metrology and processing tools. This event is not merely a series of lectures; it is a strategic summit where partnerships are forged to secure supply chains and drive the next decade of semiconductor innovation. With the UK's growing emphasis on sovereign capability in chip manufacturing, the discussions in Coventry will play a pivotal role in shaping national and international policy. Participants will leave with a comprehensive understanding of market trends, including the impact of geopolitical shifts on material sourcing and the roadmap for 6G telecommunications.